This site is intended for health professionals only

Published on 6 July 2007

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
VLED and formula meal replacement diets best for weight loss in type 2 diabetes
Strong opiates no better than paracetamol and codeine for post-orthopaedic pain
Delayed transfer of care model 70% accurate
Campaign leads to higher level of ACS patients arriving at ED via emergency services
Non-urgent attendance by children account for a fifth of ED visits

Alert on Rocephin neonate risk

teaser

US regulators have warned of the potential risk to newborn babies associated with Roche



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Janssen-Cilag’s Stelara approved by NICE
4
Merck agrees huge Vioxx settlement
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Alutard may reduce asthma risk
ValiRx cancer screen method gains patent
Call for more action on fake drugs
Raptor Pharmaceuticals Corp. announces first European launch for Quinsair®
Combination treatment could be key to treating patients with advanced NET